SCHEMBL24322898

SCHEMBL24322898

CC[C@H](C)[C@H]1C(=O)NCCN1S(=O)(=O)c1ccc(C)cc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.56
MAPT P10636 2/20 0.56
POLB P06746 1/20 0.56
KMT2A Q03164 2/20 0.44
BDKRB1 P46663 2/20 0.42
GAA P10253 3/20 0.42
CYP3A4 P08684 2/20 0.42
CYP2C19 P33261 2/20 0.42
NPSR1 Q6W5P4 1/20 0.41
ELANE P08246 1/20 0.41
LMNA P02545 2/20 0.40
TSHR P16473 2/20 0.40
RECQL P46063 1/20 0.39
L3MBTL1 Q9Y468 2/20 0.39
MCOLN3 Q8TDD5 1/20 0.39
MMP2 P08253 1/20 0.39
ANPEP P15144 1/20 0.39
CYP2D6 P10635 1/20 0.38
CYP2C9 P11712 1/20 0.38
PKM P14618 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL32665653 0.78 ALDH1A1 (0.58) ALDH1A1MAPTPOLBKMT2AGAA
SCHEMBL4339959 0.74 ALDH1A1 (0.64) ALDH1A1MAPTPOLBKMT2ABDKRB1
SCHEMBL4339955 0.74 ALDH1A1 (0.64) ALDH1A1MAPTPOLBKMT2ABDKRB1
SCHEMBL7129580 0.73 LMNA (0.46) ALDH1A1POLBKMT2AGAACYP3A4
SCHEMBL7129583 0.73 LMNA (0.46) ALDH1A1POLBKMT2AGAACYP3A4
SCHEMBL7129578 0.73 LMNA (0.46) ALDH1A1POLBKMT2AGAACYP3A4
SCHEMBL3534971 0.73 ALDH1A1 (0.76) ALDH1A1MAPTPOLBKMT2ABDKRB1
SCHEMBL3534966 0.73 ALDH1A1 (0.76) ALDH1A1MAPTPOLBKMT2ABDKRB1
SCHEMBL5982557 0.72 ALDH1A1 (0.74) ALDH1A1MAPTPOLBKMT2ABDKRB1
SCHEMBL5982477 0.72 ALDH1A1 (0.74) ALDH1A1MAPTPOLBKMT2ABDKRB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220122691-A1 HtrA Inhibitors and CagA Inhibitors and Use Thereof Psomagen Inc. (US) 2022-04-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220122691-A1 HtrA Inhibitors and CagA Inhibitors and Use Thereof HTRA1, GIPR, HPN ALDH1A1 4556/4885MAPT 4494/4885POLB 4461/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.